{"id":48889,"date":"2026-02-20T10:00:38","date_gmt":"2026-02-20T10:00:38","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/t-cell-immunotherapy-market-mordor\/"},"modified":"2026-10-30T13:50:30","modified_gmt":"2026-10-30T04:50:30","slug":"t-cell-immunotherapy-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/t-cell-immunotherapy-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 T\uc138\ud3ec \uba74\uc5ed\uce58\ub8cc \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2025-2030\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/t-cell-immunotherapy-market-1757570616601-major-players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/t-cell-immunotherapy-market-size-image-1757567989854.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc99d\uac00\ud558\ub294 \uc804 \uc138\uacc4 \uc554 \ubd80\ub2f4 \ubc0f \uace0\ub839\ud654 \uc778\uad6c<\/li>\n<li class=\"toc-level-3\">4.2.2 T\uc138\ud3ec \uce58\ub8cc\uc81c\uc758 \uc801\uc751\uc99d \ud655\ub300 \ubc0f \ub77c\ubca8 \ud655\uc7a5<\/li>\n<li class=\"toc-level-3\">4.2.3 \uc720\ub9ac\ud55c \uaddc\uc81c \uacbd\ub85c \ubc0f \uc2e0\uc18d \uc2b9\uc778 \ud504\ub85c\uadf8\ub7a8<\/li>\n<li class=\"toc-level-3\">4.2.4 \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc \uc778\ud504\ub77c\uc5d0 \ub300\ud55c \ud22c\uc790 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.5 \uc138\ud3ec \uacf5\ud559 \ubc0f \uc81c\uc870 \uc790\ub3d9\ud654\uc758 \uae30\uc220 \ubc1c\uc804<\/li>\n<li class=\"toc-level-3\">4.2.6 \uc81c\uc57d, \ubc14\uc774\uc624\ud14d \ubc0f \ud559\uacc4 \uc804\ubc18\uc758 \uc804\ub7b5\uc801 \ud611\ub825 \ubc0f \uc81c\ud734<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \ub192\uc740 \uce58\ub8cc \ube44\uc6a9 \ubc0f \ubd88\ud655\uc2e4\ud55c \ubcf4\ud5d8 \uc0c1\ud658 \ud658\uacbd<\/li>\n<li class=\"toc-level-3\">4.3.2 \ubcf5\uc7a1\ud55c \uc81c\uc870 \uacf5\uae09\ub9dd \ubc0f \uc0dd\uc0b0 \ub2a5\ub825 \uc81c\uc57d<\/li>\n<li class=\"toc-level-3\">4.3.3 \uc0ac\uc774\ud1a0\uce74\uc778 \ubc29\ucd9c \uc99d\ud6c4\uad70 \ubc0f \uc2e0\uacbd\ub3c5\uc131\uc744 \ud3ec\ud568\ud55c \uc548\uc804\uc131 \ubb38\uc81c<\/li>\n<li class=\"toc-level-3\">4.3.4 \ub300\uccb4 \uba74\uc5ed \uce58\ub8cc \uc591\uc2dd\uc73c\ub85c\ubd80\ud130\uc758 \uacbd\uc7c1 \uc555\ub825<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uacf5\uae09\ub9dd \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">4.5 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.6 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.7 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.7.1 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.3 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uce58\ub8cc \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 CAR-T<\/li>\n<li class=\"toc-level-3\">5.1.2 TCR-T<\/li>\n<li class=\"toc-level-3\">5.1.3 TIL<\/li>\n<li class=\"toc-level-3\">5.1.4 ?? T-\uc138\ud3ec<\/li>\n<li class=\"toc-level-3\">5.1.5 \uae30\ud0c0 (CAAR-T, MILs)<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uc801\uc751\uc99d\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \ud608\uc561\uc554<\/li>\n<li class=\"toc-level-3\">5.2.2 \uace0\ud615\uc554<\/li>\n<li class=\"toc-level-3\">5.2.3 \uc790\uac00\uba74\uc5ed \uc9c8\ud658<\/li>\n<li class=\"toc-level-3\">5.2.4 \ubc14\uc774\ub7ec\uc2a4 \uac10\uc5fc<\/li>\n<li class=\"toc-level-3\">5.2.5 \uae30\ud0c0 (\ud76c\uadc0\uc554)<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.3.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.3.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.3.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.3.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.3.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.3.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.3.2.6 \uc720\ub7fd \uae30\ud0c0 \uc9c0\uc5ed<\/li>\n<li class=\"toc-level-3\">5.3.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.3.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.3.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.3.3.4 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.3.3.5 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.3.3.6 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uae30\ud0c0 \uc9c0\uc5ed<\/li>\n<li class=\"toc-level-3\">5.3.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.3.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.3.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.3.4.3 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74 \uae30\ud0c0 \uc9c0\uc5ed<\/li>\n<li class=\"toc-level-3\">5.3.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.3.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.3.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.3.5.3 \ub0a8\ubbf8 \uae30\ud0c0 \uc9c0\uc5ed<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 {(\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4 (\uc0ac\uc6a9 \uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5\uc758 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)}\n<ul>\n<li class=\"toc-level-3\">6.3.1 Novartis AG<\/li>\n<li class=\"toc-level-3\">6.3.2 Gilead Sciences (Kite Pharma)<\/li>\n<li class=\"toc-level-3\">6.3.3 Bristol Myers Squibb<\/li>\n<li class=\"toc-level-3\">6.3.4 Johnson &amp; Johnson \/ Legend Biotech<\/li>\n<li class=\"toc-level-3\">6.3.5 Iovance Biotherapeutics<\/li>\n<li class=\"toc-level-3\">6.3.6 Adaptimmune Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.7 Allogene Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.8 Cellectis SA<\/li>\n<li class=\"toc-level-3\">6.3.9 CRISPR Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.10 TCR2 Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.11 Atara Biotherapeutics<\/li>\n<li class=\"toc-level-3\">6.3.12 Autolus Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.13 Bluebird Bio<\/li>\n<li class=\"toc-level-3\">6.3.14 Caribou Biosciences<\/li>\n<li class=\"toc-level-3\">6.3.15 Poseida Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.16 Fate Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.17 ImmunityBio (NantKwest)<\/li>\n<li class=\"toc-level-3\">6.3.18 Turnstone Biologics<\/li>\n<li class=\"toc-level-3\">6.3.19 Sorrento Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.20 BeiGene Ltd.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>T\uc138\ud3ec \uba74\uc5ed\uce58\ub8cc\uc81c \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2025-2030)<\/p>\n<p>1. \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc8fc\uc694 \uc218\uce58<\/p>\n<p>T\uc138\ud3ec \uba74\uc5ed\uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 2025\ub144 39\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\uc5d0\uc11c 2030\ub144\uc5d0\ub294 327\uc5b5 5\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub418\uba70, \uc608\uce21 \uae30\uac04(2025-2030\ub144) \ub3d9\uc548 35.30%\uc758 \ub192\uc740 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR)\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc740 \uc8fc\ub85c \uc885\uc591\ud559 \ubd84\uc57c\uc5d0\uc11c\uc758 \ucc44\ud0dd \uc99d\uac00, \uc870\uae30 \uce58\ub8cc \ub77c\uc778 \uc2b9\uc778 \ud655\ub300, \uadf8\ub9ac\uace0 \ud658\uc790 \uc801\uaca9\uc131\uc744 \ub113\ud788\ub294 \uac00\uc18d\ud654\ub41c \ubcf4\ud5d8 \uc0c1\ud658 \uc2dc\ubc94 \ud504\ub85c\uadf8\ub7a8 \ub4f1\uc5d0 \uae30\uc778\ud569\ub2c8\ub2e4. \uc784\uc0c1\uc801 \ubaa8\uba58\ud140\uc740 B\uc138\ud3ec \uc545\uc131\uc885\uc591\uc744 \ub118\uc5b4 \uace0\ud615\uc554 \ubd84\uc57c\ub85c \ud655\uc7a5\ub418\uace0 \uc788\uc73c\uba70, \uc790\ub3d9\ud654 \uae30\uc220\uc740 \uc0dd\uc0b0 \uc7ac\ud604\uc131\uc744 \ud5a5\uc0c1\uc2dc\ud0a4\uace0 \uc0dd\uc0b0 \ub9ac\ub4dc \ud0c0\uc784\uc744 \ub2e8\ucd95\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubbf8\uad6d \uc2dd\ud488\uc758\uc57d\uad6d(FDA)\uacfc \uc720\ub7fd\uc758\uc57d\ud488\uccad(EMA) \uac04\uc758 \uaddc\uc81c \uc870\ud654\ub294 \uac1c\ubc1c \ub9c8\ucc30\uc744 \uc904\uc774\uace0 \uc788\uc73c\uba70, \uac00\uce58 \uae30\ubc18 \uacc4\uc57d\uc740 \uace0\uac00\uc758 \uce58\ub8cc \ube44\uc6a9\uc5d0 \ub300\ud55c \uc9c0\ubd88\uc790\uc758 \uc6b0\ub824\ub97c \uc644\ud654\ud558\uae30 \uc2dc\uc791\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \uc5f0\uad6c \uae30\uac04: 2019\ub144 &#8211; 2030\ub144<br \/>\n*   2025\ub144 \uc2dc\uc7a5 \uaddc\ubaa8: 39\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec<br \/>\n*   2030\ub144 \uc2dc\uc7a5 \uaddc\ubaa8: 327\uc5b5 5\ucc9c\ub9cc \ub2ec\ub7ec<br \/>\n*   \uc131\uc7a5\ub960 (2025-2030\ub144): 35.30% CAGR<br \/>\n*   \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5: \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<br \/>\n*   \uac00\uc7a5 \ud070 \uc2dc\uc7a5: \ubd81\ubbf8<br \/>\n*   \uc2dc\uc7a5 \uc9d1\uc911\ub3c4: \uc911\uac04<\/p>\n<p>2. \uc8fc\uc694 \ubcf4\uace0\uc11c \uc694\uc57d<\/p>\n<p>*   \uce58\ub8cc \uc720\ud615\ubcc4: \ud0a4\uba54\ub77c \ud56d\uc6d0 \uc218\uc6a9\uccb4 T\uc138\ud3ec(CAR-T)\uac00 2024\ub144 T\uc138\ud3ec \uba74\uc5ed\uce58\ub8cc\uc81c \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 95.7%\ub97c \ucc28\uc9c0\ud558\uba70 \uc9c0\ubc30\uc801\uc778 \uc704\uce58\ub97c \uc720\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \ud55c\ud3b8, \ub3d9\uc885(Allogeneic) CAR-T \uce58\ub8cc\uc81c\ub294 2025\ub144\ubd80\ud130 2030\ub144\uae4c\uc9c0 32.6%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc801\uc751\uc99d\ubcc4: \ud608\uc561\uc554\uc774 2024\ub144 T\uc138\ud3ec \uba74\uc5ed\uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 83.2%\ub97c \ucc28\uc9c0\ud558\uba70 \uac00\uc7a5 \ud070 \ube44\uc911\uc744 \ubcf4\uc600\uc2b5\ub2c8\ub2e4. \uace0\ud615\uc554\uc740 2030\ub144\uae4c\uc9c0 35.4%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: \ubd81\ubbf8\uac00 2024\ub144 T\uc138\ud3ec \uba74\uc5ed\uce58\ub8cc\uc81c \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 53.4%\ub85c \uc120\ub450\ub97c \ub2ec\ub838\uc2b5\ub2c8\ub2e4. \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 2030\ub144\uae4c\uc9c0 25.2%\uc758 CAGR\uc744 \uae30\ub85d\ud558\uba70 \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>3. \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30 (\uc131\uc7a5 \ub3d9\uc778)<\/p>\n<p>T\uc138\ud3ec \uba74\uc5ed\uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uacac\uc778\ud558\ub294 \uc8fc\uc694 \ub3d9\uc778\uc740 \ub2e4\uc74c\uacfc \uac19\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \uc804 \uc138\uacc4 \uc554 \ubd80\ub2f4 \ubc0f \uace0\ub839\ud654 \uc778\uad6c \uc99d\uac00 (+8.20% \uc601\ud5a5): \uc784\uc0c1 \uc2dc\ud5d8 \uc778\ud504\ub77c\uac00 \uc81c\ud55c\uc801\uc778 \uacbd\uc81c\uad8c\uc5d0\uc11c \uc554 \ubc1c\uc0dd\ub960\uc774 \uac00\uc7a5 \ube60\ub974\uac8c \uc99d\uac00\ud558\uace0 \uc788\uc73c\uba70, \ubbf8\uad6d\uacfc \uc720\ub7fd\uc758 \uace0\ub839\ud654 \uc778\uad6c\ub294 \uc790\uac00 \ubc0f \ub3d9\uc885 CAR-T \ud45c\uc801\uacfc \uc798 \ub9de\ub294 \ud608\uc561\uc554 \ubc1c\ubcd1\ub960\uc774 \ub192\uc2b5\ub2c8\ub2e4. \uc911\uad6d\uc740 \uc138\uacc4\uc5d0\uc11c \uac00\uc7a5 \ud070 \uc885\uc591 \ud658\uc790 \ucf54\ud638\ud2b8\ub97c \ubcf4\uc720\ud558\uace0 \uc788\uc73c\uba70 300\uac1c \uc774\uc0c1\uc758 CAR-T \uc784\uc0c1 \uc2dc\ud5d8\uc744 \uc9c4\ud589\ud558\uba70 \ubbf8\uad6d\uacfc \ud568\uaed8 \uc120\ub450\ub97c \ub2ec\ub9ac\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc778\uad6c \ud1b5\uacc4\ud559\uc801 \ucd94\uc138\ub294 \uce58\ub8cc \ubaa9\uc801\uc758 \uce58\ub8cc\ubc95\uc5d0 \ub300\ud55c \uc9c0\uc18d\uc801\uc778 \uc218\uc694\ub97c \ubcf4\uc7a5\ud558\uba70 T\uc138\ud3ec \uba74\uc5ed\uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 \uc7a5\uae30\uc801\uc778 \uada4\ub3c4\ub97c \ub4b7\ubc1b\uce68\ud569\ub2c8\ub2e4.<br \/>\n*   T\uc138\ud3ec \uce58\ub8cc\uc81c\uc758 \uc801\uc751\uc99d \ud655\ub300 \ubc0f \ub77c\ubca8 \ud655\uc7a5 (+6.80% \uc601\ud5a5): 2024\ub144 FDA\uac00 \uc804\uc774\uc131 \ud65c\ub9c9 \uc721\uc885\uc5d0 \ub300\ud574 \uc544\ud30c\ubbf8\ud2b8\ub808\uc2a4\uc9c4 \uc624\ud1a0\ub958\uc140(afamitresgene autoleucel)\uc744 \uc2b9\uc778\ud558\uba70 \uace0\ud615\uc554 \uce58\ub8cc\uc758 \ubb38\uc744 \uc5f4\uc5c8\uc2b5\ub2c8\ub2e4. \ud6c4\uc18d \uc2b9\uc778\ub4e4\uc740 \uc870\uae30 \uce58\ub8cc \ub77c\uc778\uc73c\ub85c \ud655\ub300\ub418\ub294 \ucd94\uc138\uc774\uba70, \uc774\ub294 \uce58\ub8cc \uac00\ub2a5\ud55c \ud658\uc790 \uc218\ub97c \uac70\uc758 \uc808\ubc18 \uac00\uae4c\uc774 \ub298\ub9bd\ub2c8\ub2e4. \ub8e8\ud478\uc2a4 \ubc0f \uae30\ud0c0 \uc790\uac00\uba74\uc5ed \uc9c8\ud658\uc744 \ud45c\uc801\uc73c\ub85c \ud558\ub294 \ud30c\uc774\ud504\ub77c\uc778 \ud504\ub85c\uadf8\ub7a8\uc740 \uc885\uc591\ud559\uc744 \ub118\uc5b4\uc120 \ubbf8\ub798 \ub2e4\uac01\ud654 \uac00\ub2a5\uc131\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. ISO \ubc0f GMP \ud504\ub808\uc784\uc6cc\ud06c\uc758 \uc870\ud654\ub294 \uc0c8\ub85c\uc6b4 \uc801\uc751\uc99d\uc5d0 \ub9de\ucdb0 \uc548\uc804\uc131 \uac10\uc2dc\uac00 \ud655\uc7a5\ub418\ub3c4\ub85d \ubcf4\uc7a5\ud569\ub2c8\ub2e4.<br \/>\n*   \uc6b0\ud638\uc801\uc778 \uaddc\uc81c \uacbd\ub85c \ubc0f \uc2e0\uc18d \uc2b9\uc778 \ud504\ub85c\uadf8\ub7a8 (+5.40% \uc601\ud5a5): CoGenT Global \ud30c\uc77c\ub7ff \ud504\ub85c\uadf8\ub7a8\uc740 \ub2e4\uc9c0\uc5ed \uc81c\ucd9c\uc744 \uac04\uc18c\ud654\ud558\uace0 \uac80\ud1a0 \uc8fc\uae30\ub97c \ub2e8\ucd95\ud558\ub294 \uae30\uad00 \uac04 \ud611\ub825\uc744 \uacf5\uc2dd\ud654\ud569\ub2c8\ub2e4. RMAT \ubc0f PRIME \uc9c0\uc815\uc740 \uc784\uc0c1 \uac1c\ubc1c \uae30\uac04\uc744 \ub2e8\ucd95\ud558\uba70, 2025\ub144 6\uc6d4 \uc790\uac00 \uc81c\ud488\uc5d0 \ub300\ud55c REMS(\uc704\ud5d8 \ud3c9\uac00 \ubc0f \uc644\ud654 \uc804\ub7b5) \uc81c\uac70\ub294 \ud2b9\ud788 \ub18d\ucd0c \uc9c0\uc5ed\uc758 \uc8fc\uc785 \uc13c\ud130 \uc6b4\uc601 \ubd80\ub2f4\uc744 \uc904\uc785\ub2c8\ub2e4. \uaddc\uc81c \ub2f9\uad6d\uc740 2025\ub144\uae4c\uc9c0 \ub9e4\ub144 10~20\uac1c\uc758 \uc2e0\uaddc \uc2b9\uc778\uc744 \uc608\uc0c1\ud558\uba70, \uc774\ub294 T\uc138\ud3ec \uba74\uc5ed\uce58\ub8cc\uc81c \uc2dc\uc7a5\uc774 \ubc14\uc774\uc624 \uc81c\uc57d \ubd84\uc57c\uc5d0\uc11c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \ubd80\ubb38 \uc911 \ud558\ub098\uc784\uc744 \uc785\uc99d\ud569\ub2c8\ub2e4.<br \/>\n*   \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc \uc778\ud504\ub77c \ud22c\uc790 \uc99d\uac00 (+4.90% \uc601\ud5a5): \ube0c\ub9ac\uc2a4\ud1a8 \ub9c8\uc774\uc5b4\uc2a4 \uc2a4\ud045(Bristol Myers Squibb)\uc740 \uc140\ub77c\ub808\uc2a4(Cellares)\uc640 3\uc5b5 8\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\uc758 \uc0dd\uc0b0 \ub2a5\ub825 \uc608\uc57d \uacc4\uc57d\uc744 \uccb4\uacb0\ud558\uc5ec \uc624\uc5fc \uc704\ud5d8\uc744 \ub0ae\ucd94\uace0 \ubc30\uce58 \uac04 \uc77c\uad00\uc131\uc744 \ub192\uc774\ub294 \uc790\ub3d9\ud654\ub41c \ud3d0\uc1c4\ud615 \uc2dc\uc2a4\ud15c\uc73c\ub85c \uc804\ud658\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uae38\ub9ac\uc5b4\ub4dc \uc0ac\uc774\uc5b8\uc2a4(Gilead Sciences)\ub294 2026\ub144\uae4c\uc9c0 CAR-T \uc0dd\uc0b0\ub7c9\uc744 4\ubc30\ub85c \ub298\ub9b4 \uacc4\ud68d\uc785\ub2c8\ub2e4. \uace0\ubc00\ub3c4 \ubbf8\uc138\uc720\uccb4 \uc0dd\ubb3c\ubc18\uc751\uae30\ub294 \uc804\ud1b5\uc801\uc778 \uc815\uc801 \ubc30\uc591\uc744 \ub118\uc5b4 \uc0dd\uc0b0\ub7c9\uc744 \ub298\ub824 \uc0dd\uc0b0 \ube44\uc6a9\uc744 \uc808\uac10\ud558\uace0 T\uc138\ud3ec \uba74\uc5ed\uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 \uacbd\uc81c\uc131\uc744 \uac15\ud654\ud569\ub2c8\ub2e4.<br \/>\n*   \uc138\ud3ec \uacf5\ud559 \ubc0f \uc81c\uc870 \uc790\ub3d9\ud654 \uae30\uc220 \ubc1c\uc804 (+3.80% \uc601\ud5a5): \uc790\ub3d9\ud654\ub41c \uc2dc\uc2a4\ud15c\uc740 \uc0dd\uc0b0 \ub9ac\ub4dc \ud0c0\uc784\uc744 \ub2e8\ucd95\ud558\uace0 \ubc30\uce58 \uc131\uacf5\ub960\uc744 \ub192\uc5ec \uc81c\uc870 \ud6a8\uc728\uc131\uc744 \ud06c\uac8c \ud5a5\uc0c1\uc2dc\ud0b5\ub2c8\ub2e4. \uc774\ub294 \ud2b9\ud788 \uc790\uac00 \uce58\ub8cc\uc81c\uc758 \uc0c1\uc5c5\uc801 \uc2e4\ud589 \uac00\ub2a5\uc131\uc744 \ub192\uc774\uace0 \ud655\uc7a5 \uac00\ub2a5\ud55c \ub3d9\uc885 \uce58\ub8cc\uc81c \ucd9c\uc2dc\ub97c \uc704\ud55c \uae30\ubc18\uc744 \ub9c8\ub828\ud569\ub2c8\ub2e4.<br \/>\n*   \uc81c\uc57d, \ubc14\uc774\uc624\ud14d, \ud559\uacc4 \uac04 \uc804\ub7b5\uc801 \ud611\ub825 (+2.90% \uc601\ud5a5): \ub2e4\uc591\ud55c \uc774\ud574\uad00\uacc4\uc790 \uac04\uc758 \ud611\ub825\uc740 \uc5f0\uad6c \uac1c\ubc1c\uc744 \uac00\uc18d\ud654\ud558\uace0 \uc0c8\ub85c\uc6b4 \uce58\ub8cc\ubc95\uc758 \uc2dc\uc7a5 \ucd9c\uc2dc\ub97c \ucd09\uc9c4\ud569\ub2c8\ub2e4.<\/p>\n<p>4. \uc8fc\uc694 \uc81c\uc57d \uc694\uc778<\/p>\n<p>\uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc740 \ub2e4\uc74c\uacfc \uac19\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \ub192\uc740 \uce58\ub8cc \ube44\uc6a9 \ubc0f \ubd88\ud655\uc2e4\ud55c \ubcf4\ud5d8 \uc0c1\ud658 \ud658\uacbd (-4.10% \uc601\ud5a5): \uce58\ub8cc\ub2f9 \ud3c9\uade0 30\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 425\ub9cc \ub2ec\ub7ec\uc5d0 \ub2ec\ud558\ub294 \ub192\uc740 \uac00\uaca9\uc740 \uacf5\uacf5 \ubc0f \ubbfc\uac04 \uc758\ub8cc \uc2dc\uc2a4\ud15c \ubaa8\ub450\uc5d0\uc11c \ucc44\ud0dd\uc744 \ubc29\ud574\ud569\ub2c8\ub2e4. \ubbf8\uad6d\uc758 \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc \uc811\uadfc \ubaa8\ub378(Cell and Gene Therapy Access Model)\uc740 2025\ub144\uc5d0 \uc131\uacfc \uae30\ubc18 \uacc4\uc57d\uc744 \uc2dc\uc791\ud558\uc9c0\ub9cc, \uc6b4\uc601 \ubcf5\uc7a1\uc131\uacfc \ub370\uc774\ud130 \ucd94\uc801 \uc694\uad6c \uc0ac\ud56d\uc73c\ub85c \uc778\ud574 \ucd08\uae30 \ucc44\ud0dd\uc774 \uc9c0\uc5f0\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc911\uad6d\uc5d0\uc11c\ub294 \uc81c\ud55c\uc801\uc778 \ubcf4\ud5d8 \uc0c1\ud658\uc73c\ub85c \uc778\ud574 \ub300\ubd80\ubd84\uc758 \ud658\uc790\uac00 \uac1c\uc778 \uc800\ucd95\uc5d0 \uc758\uc874\ud558\uace0 \uc788\uc5b4 \uc784\uc0c1 \uc2dc\ud5d8 \ucc38\uc5ec\uc5d0\uc11c \uc0c1\uc5c5\uc801 \uce58\ub8cc\ub85c\uc758 \uc804\ud658\uc774 \ub2a6\uc5b4\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ubcf5\uc7a1\ud55c \uc81c\uc870 \uacf5\uae09\ub9dd \ubc0f \uc0dd\uc0b0 \ub2a5\ub825 \uc81c\uc57d (-3.70% \uc601\ud5a5): \uc790\uac00 \uce58\ub8cc\uc81c\ub294 \ubc31\ud608\uad6c \ubd84\ub9ac \ucc44\ucde8\ubd80\ud130 \uc8fc\uc785\uae4c\uc9c0 3~5\uc8fc\uac00 \uc18c\uc694\ub418\uc5b4 \uc784\uc0c1\uc758\uac00 \uce58\ub8cc \ud6a8\uacfc\ub97c \uc57d\ud654\uc2dc\ud0ac \uc218 \uc788\ub294 \uac00\uad50 \ud654\ud559\uc694\ubc95\uc744 \ud22c\uc5ec\ud574\uc57c \ud569\ub2c8\ub2e4. CDMO(\uacc4\uc57d \uac1c\ubc1c \ubc0f \uc81c\uc870 \uc870\uc9c1)\ub294 \uc5ec\uc804\ud788 \uc0c1\uc5c5\uc801 \ud65c\uc6a9\ub960\uc774 50% \ubbf8\ub9cc\uc774\uc5b4\uc11c \uc784\uc0c1 \uc218\uc694\uc640 \uc0b0\uc5c5 \uc0dd\uc0b0 \ub2a5\ub825 \uac04\uc758 \ubd88\uade0\ud615\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \ub2e4\ub2e8\uacc4 \ud488\uc9c8 \uad00\ub9ac(\ub9c8\uc774\ucf54\ud50c\ub77c\uc2a4\ub9c8 \ubc0f \ubb34\uade0\uc131 \ud14c\uc2a4\ud2b8 \ud3ec\ud568)\ub294 \ucd9c\uc2dc \uae30\uac04\uc744 \ub298\ub9ac\uace0 \ubc30\uce58 \uc2e4\ud328 \ud655\ub960\uc744 \ub192\uc785\ub2c8\ub2e4.<br \/>\n*   \uc0ac\uc774\ud1a0\uce74\uc778 \ubc29\ucd9c \uc99d\ud6c4\uad70 \ubc0f \uc2e0\uacbd\ub3c5\uc131 \ub4f1 \uc548\uc804\uc131 \ubb38\uc81c (-2.80% \uc601\ud5a5): T\uc138\ud3ec \uba74\uc5ed\uce58\ub8cc\uc81c\ub294 \uc0ac\uc774\ud1a0\uce74\uc778 \ubc29\ucd9c \uc99d\ud6c4\uad70(CRS) \ubc0f \uc2e0\uacbd\ub3c5\uc131(ICANS)\uacfc \uac19\uc740 \uc2ec\uac01\ud55c \ubd80\uc791\uc6a9\uc744 \uc720\ubc1c\ud560 \uc218 \uc788\uc73c\uba70, \uc774\ub294 \ud658\uc790 \uc548\uc804\uc5d0 \ub300\ud55c \uc6b0\ub824\ub97c \uc81c\uae30\ud558\uace0 \uaddc\uc81c \ub2f9\uad6d\uc758 \uba74\ubc00\ud55c \uc870\uc0ac\ub97c \ubc1b\uac8c \ud569\ub2c8\ub2e4.<br \/>\n*   \ub300\uccb4 \uba74\uc5ed\uce58\ub8cc\ubc95\uacfc\uc758 \uacbd\uc7c1 \uc555\ub825 (-2.20% \uc601\ud5a5): \uc774\uc911 \ud2b9\uc774\uc131 \ud56d\uccb4, \uba74\uc5ed\uad00\ubb38 \uc5b5\uc81c\uc81c \ub4f1 \ub2e4\ub978 \uba74\uc5ed\uce58\ub8cc\ubc95\uc758 \ubc1c\uc804\uc740 T\uc138\ud3ec \uba74\uc5ed\uce58\ub8cc\uc81c \uc2dc\uc7a5\uc5d0 \uacbd\uc7c1 \uc555\ub825\uc744 \uac00\ud569\ub2c8\ub2e4.<\/p>\n<p>5. \uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d<\/p>\n<p>5.1. \uce58\ub8cc \uc720\ud615\ubcc4: \ub3d9\uc885 \uce58\ub8cc\uc81c\uc758 \ubd80\uc0c1\uacfc CAR-T \ub9ac\ub354\uc2ed \uc7ac\ud3b8<\/p>\n<p>*   \uc790\uac00 CAR-T \uce58\ub8cc\uc81c: \ud0b4\ub9ac\uc544(Kymriah) \ubc0f \uc608\uc2a4\uce74\ub974\ud0c0(Yescarta)\uc640 \uac19\uc740 \uc790\uac00 CAR-T \uc81c\ud488\uc740 2024\ub144 T\uc138\ud3ec \uba74\uc5ed\uce58\ub8cc\uc81c \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 95.7%\ub97c \ucc28\uc9c0\ud558\uba70 B\uc138\ud3ec \uc545\uc131\uc885\uc591\uc5d0\uc11c \uac15\ub825\ud55c \uad00\ud574 \uc9c0\uc18d\uc131\uc744 \ubcf4\uc5ec\uc8fc\uc5c8\uc2b5\ub2c8\ub2e4. \uc790\uac00 \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uaddc\ubaa8\ub294 20% \ud6c4\ubc18\ub300\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uc9c0\ub9cc, \uc81c\uc870 \ud55c\uacc4\ub85c \uc778\ud574 \uc808\ub300\uc801\uc778 \ubb3c\ub7c9 \uc131\uc7a5\uc740 \uc81c\ud55c\uc801\uc785\ub2c8\ub2e4.<br \/>\n*   \ub3d9\uc885 CAR-T \uce58\ub8cc\uc81c: \ub3d9\uc885 CAR-T \uc811\uadfc\ubc95\uc740 2030\ub144\uae4c\uc9c0 32.6%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub294 \uc774\uc2dd\ud3b8\ub300\uc219\uc8fc\ubcd1(GvHD) \uc6b0\ub824\ub97c \uc911\ud654\ud558\ub294 CRISPR \ubc0f \uc5fc\uae30 \ud3b8\uc9d1 \ud50c\ub7ab\ud3fc\uc5d0 \uc758\ud574 \ucd94\uc9c4\ub429\ub2c8\ub2e4. \ubcd1\uc6d0\ub4e4\uc740 \uc989\uc2dc \uc0ac\uc6a9 \uac00\ub2a5\ud55c &#8220;\uae30\uc131\ud488(off-the-shelf)&#8221; \ud2b9\uc131 \ub54c\ubb38\uc5d0 \ub3d9\uc885 \uce58\ub8cc\uc81c\ub97c \uc120\ud638\ud558\uba70, \uc774\ub294 \uae09\uc131 \uc885\uc591\ud559 \uce58\ub8cc \uc77c\uc815\uacfc \uc798 \ub9de\uc2b5\ub2c8\ub2e4. ALLO-501\uc774 \ub300\ud615 B\uc138\ud3ec \ub9bc\ud504\uc885\uc5d0\uc11c 58%\uc758 \uc804\uccb4 \ubc18\uc751\ub960\uc744 \ubcf4\uc778 \uc784\uc0c1 \uc99d\uac70\ub294 \uc790\uac00 \uce58\ub8cc\uc81c\uc640 \ub3d9\ub4f1\ud55c \ud6a8\ub2a5\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4. \ub3d9\uc885 \uce58\ub8cc\uc81c\uc758 \ud655\uc7a5\uc131\uc740 \ud604\uc7ac \uc18c\uc218\uc758 \uc801\uaca9 \ud658\uc790\uc5d0\uac8c\ub9cc \uc8fc\uc785 \uae30\ud68c\ub97c \uc81c\ud55c\ud558\ub294 \ud6c4\ubc29 \ubcd1\ubaa9 \ud604\uc0c1\uc744 \ud574\uacb0\ud569\ub2c8\ub2e4. \ud3d0\uc1c4\ud615 \uc2dc\uc2a4\ud15c \uc0dd\ubb3c\ubc18\uc751\uae30 \ubc0f \uc790\ub3d9\ud654\ub41c \ucda9\uc804-\ub9c8\uac10 \uc124\ube44\uac00 \uac00\ub3d9\ub428\uc5d0 \ub530\ub77c \ud658\uc790\ub2f9 \uc81c\uc870 \ube44\uc6a9\uc774 \uc808\uac10\ub418\uc5b4 T\uc138\ud3ec \uba74\uc5ed\uce58\ub8cc\uc81c \uc2dc\uc7a5 \ub0b4\uc5d0\uc11c \uc811\uadfc \uac00\ub2a5\ud55c \uae30\ubc18\uc774 \ud655\ub300\ub420 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>5.2. \uc801\uc751\uc99d\ubcc4: \ud608\uc561\uc554\uc758 \uac15\uc138\uc640 \uace0\ud615\uc554\uc758 \uc131\uc7a5 \uc7a0\uc7ac\ub825<\/p>\n<p>*   \ud608\uc561\uc554: \ud608\uc561\uc554\uc740 2024\ub144 T\uc138\ud3ec \uba74\uc5ed\uce58\ub8cc\uc81c \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 83%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. CD19, BCMA, CD22\uc640 \uac19\uc740 \uac80\uc99d\ub41c \ud56d\uc6d0\uc740 \uc608\uce21 \uac00\ub2a5\ud55c \uc81c\uc870 \uacb0\uacfc\uc640 \uac15\ub825\ud55c \uc644\uc804 \uad00\ud574\uc728\ub85c \uc774\uc5b4\uc838 \uc2dc\uc7a5\uc744 \uacac\uc778\ud588\uc2b5\ub2c8\ub2e4. \ub2e4\ubc1c\uc131 \uace8\uc218\uc885 \ubc0f \ubbf8\ub9cc\uc131 \uac70\ub300 B\uc138\ud3ec \ub9bc\ud504\uc885\uc5d0\uc11c\uc758 \uc870\uae30 \uce58\ub8cc \ub77c\uc778 \uc2b9\uc778\uc740 \uc808\ub300\uc801\uc778 \ud658\uc790 \ud480\uc744 \ud655\ub300\ud558\uace0 \uce58\ub8cc \uae30\uac04 \ud61c\ud0dd\uc744 \uc5f0\uc7a5\ud569\ub2c8\ub2e4.<br \/>\n*   \uace0\ud615\uc554: \uace0\ud615\uc554\uc740 2030\ub144\uae4c\uc9c0 35.4%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5 \uada4\uc801\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ud65c\ub9c9 \uc721\uc885\uc5d0 \ub300\ud55c \ud14c\uc140\ub77c(Tecelra) \uc2b9\uc778\uacfc \uc885\uc591 \ubbf8\uc138 \ud658\uacbd \uc870\uc808 \uad6c\uc870 \uc124\uacc4\uc758 \uae09\uc99d\uc774 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub098\ub178\ubc14\ub514 \uae30\ubc18 CAR-T \ubc0f \uac15\ud654 T\uc138\ud3ec\ub294 \uba74\uc5ed\uc5b5\uc81c \uc7a5\ubcbd\uc744 \ud574\uccb4\ud558\uace0 \ubc00\uc9d1\ub41c \uc885\uc591 \uae30\uc9c8\ub85c\uc758 \uc774\ub3d9\uc744 \uac1c\uc120\ud558\ub294 \uac83\uc744 \ubaa9\ud45c\ub85c \ud569\ub2c8\ub2e4. \uc2e0\uc7a5 \uc138\ud3ec\uc554 \ubc0f \uad50\ubaa8\uc138\ud3ec\uc885\uc5d0\uc11c\uc758 \uae0d\uc815\uc801\uc778 \ucd08\uae30 \uc2e0\ud638\ub294 \ud30c\uc774\ud504\ub77c\uc778 \ud655\ub300\ub97c \ub4b7\ubc1b\uce68\ud558\uba70, \uac04\ub3d9\ub9e5 \uc8fc\uc785\uacfc \uac19\uc740 \uad6d\uc18c \uc804\ub2ec \ubc29\ubc95\uc740 \uc628\ud0c0\uac9f-\uc624\ud504\ud29c\uba38 \ub3c5\uc131 \ubb38\uc81c\ub97c \ud574\uacb0\ud569\ub2c8\ub2e4. \ud76c\uadc0 \uc0c1\ud53c\uc554\uc5d0\uc11c\uc758 \ud601\uc2e0 \uce58\ub8cc\uc81c \uc9c0\uc815\uc740 \ud76c\uadc0 \uc758\uc57d\ud488 \uc778\uc13c\ud2f0\ube0c\ub97c \ud65c\uc6a9\ud558\uc5ec \uac1c\ubc1c\uc744 \uac00\uc18d\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>6. \uc9c0\uc5ed\ubcc4 \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8: 2024\ub144 T\uc138\ud3ec \uba74\uc5ed\uce58\ub8cc\uc81c \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 53.4%\ub97c \ucc28\uc9c0\ud558\uba70 \uc120\ub450\ub97c \uc720\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub294 FDA\uc758 \uc2e0\uc18d\ud55c \uac80\ud1a0 \uad6c\uc870, \uba54\ub514\ucf00\uc5b4 \ucd94\uac00 \uc9c0\ubd88, \uadf8\ub9ac\uace0 \uc778\uc99d\ub41c \uc8fc\uc785 \uc13c\ud130\uc758 \ubc00\uc9d1\ub41c \ub124\ud2b8\uc6cc\ud06c \ub355\ubd84\uc785\ub2c8\ub2e4. \ub610\ud55c, \uc774 \uc9c0\uc5ed\uc740 \ub300\ubd80\ubd84\uc758 \uc0c1\uc5c5 \uaddc\ubaa8 GMP \uc2dc\uc124\uc744 \ubcf4\uc720\ud558\uace0 \uc788\uc5b4 \ud1b5\uad00 \uc9c0\uc5f0\uc744 \ud53c\ud560 \uc218 \uc788\ub294 \uad6d\ub0b4 \uc870\ub2ec\uc774 \uac00\ub2a5\ud569\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: 25.2%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\uc744 \ubcf4\uc785\ub2c8\ub2e4. \uc911\uad6d\uc758 \ud601\uc2e0 \uce5c\ud654 \uc815\ucc45, 300\uac1c \uc774\uc0c1\uc758 \ud65c\ubc1c\ud55c CAR-T \uc784\uc0c1 \uc2dc\ud5d8, \uadf8\ub9ac\uace0 \uad6d\uac00 \ubaa9\ub85d \ub4f1\uc7ac\uc5d0 \uc55e\uc120 \uc9c0\ubc29 \uc2b9\uc778\uc774 \uc131\uc7a5\uc744 \uacac\uc778\ud569\ub2c8\ub2e4. \uc77c\ubcf8\uc758 \uc2e0\uc18d \uc7ac\uc0dd \uc758\ub8cc\ubc95\uc740 \uac80\ud1a0 \uae30\uac04\uc744 1\ub144 \ubbf8\ub9cc\uc73c\ub85c \ub2e8\ucd95\ud558\uba70, \ud55c\uad6d\uc740 GMP \uad6c\ucd95\uc5d0 \ub300\ud55c \uc138\uae08 \uacf5\uc81c\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4. \ud0c8\ub9ac\uce74\ube0c\ud0c0\uc9c4 \uc624\ud1a0\ub958\uc140(talicabtagene autoleucel)\uc5d0 \ub300\ud55c \uc778\ub3c4\uc758 \uc2b9\uc778\uc740 \uacf5\uacf5-\ubbfc\uac04 \uc81c\uc870 \ud5c8\ube0c\uc640 \uacb0\ud569\ub418\uc5b4 \uc911\uc0b0\uce35 \uc778\uad6c\ub97c \uc704\ud55c T\uc138\ud3ec \uba74\uc5ed\uce58\ub8cc\uc81c \uc2dc\uc7a5 \ud655\ub300\uc758 \uc7a0\uc7ac\ub825\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: EMA \uc870\ud654\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0 \uc644\ub9cc\ud55c \uc131\uc7a5\uc744 \ubcf4\uc774\uba70, \uad6d\uac00\ubcc4 \ucc44\ud0dd\ub960\uc5d0 \ucc28\uc774\uac00 \uc788\uc2b5\ub2c8\ub2e4(\ud504\ub791\uc2a4 30% vs. \uc774\ud0c8\ub9ac\uc544 11%). GoCART \uc5f0\ud569\uc740 \ud559\uc220 \ub178\ub4dc\ub97c \ud1b5\ud55c \uc0dd\uc0b0 \ubd84\uc0b0\ud654\ub97c \ud1b5\ud574 \uacbd\uc81c\uc131\uc744 \uc9c1\uc811\uc801\uc73c\ub85c \ub2e4\ub8e8\uba70, \uc774\ub294 \uc6a9\ub7c9\ub2f9 \ube44\uc6a9\uc744 \uc808\ubc18\uc73c\ub85c \uc904\uc77c \uc218 \uc788\ub294 \ubaa8\ub378\uc785\ub2c8\ub2e4.<br \/>\n*   \ub0a8\ubbf8: \ube0c\ub77c\uc9c8\uc740 \uc6a9\ub7c9\ub2f9 35,000\ub2ec\ub7ec\uc758 \ud30c\uaca9\uc801\uc778 \uc800\ube44\uc6a9 \ubaa8\ub378\uc744 \uc120\ubcf4\uc774\uba70, \uc811\uadfc\uc131 \ud655\ub300\ub97c \uc704\ud55c \ubbf8\ub798\uc758 \ud575\uc2ec \uc9c0\uc5ed\uc73c\ub85c \ubd80\uc0c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>7. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>T\uc138\ud3ec \uba74\uc5ed\uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 \uc911\uac04 \uc815\ub3c4\uc758 \uc9d1\uc911\ub3c4\ub97c \ubcf4\uc774\uba70, 5\uac1c\uc758 \ub2e4\uad6d\uc801 \uae30\uc5c5\uc774 \uc804 \uc138\uacc4 \ub9e4\ucd9c\uc758 70% \uc774\uc0c1\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub178\ubc14\ud2f0\uc2a4(Novartis AG)\ub294 \ud0b4\ub9ac\uc544(Kymriah)\uc758 \ub2e4\uae30\uad00 \ub77c\ubca8\ub85c \uc120\uc810 \ud6a8\uacfc\ub97c \ud65c\uc6a9\ud558\uace0 \uc788\uc73c\uba70, \uae38\ub9ac\uc5b4\ub4dc \uc0ac\uc774\uc5b8\uc2a4(Gilead Sciences)\uc758 \uc608\uc2a4\uce74\ub974\ud0c0(Yescarta)\ub294 \uc0dd\uc0b0 \ub2a5\ub825 \ud655\uc7a5 \uacc4\ud68d\uacfc \ubbf8\ub9cc\uc131 \uac70\ub300 B\uc138\ud3ec \ub9bc\ud504\uc885 \ub77c\ubca8 \ud655\uc7a5\uc744 \uae30\ubc18\uc73c\ub85c \ubb3c\ub7c9 \uba74\uc5d0\uc11c \uc55e\uc11c\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ube0c\ub9ac\uc2a4\ud1a8 \ub9c8\uc774\uc5b4\uc2a4 \uc2a4\ud045(Bristol Myers Squibb)\uc758 \ube0c\ub808\uc580\uc9c0(Breyanzi)\ub294 \uc21c\ucc28\uc801 \uc2b9\uc778\uacfc \uc790\ub3d9\ud654\ub41c \uc0dd\uc0b0 \uc5c5\uadf8\ub808\uc774\ub4dc\ub97c \ud1b5\ud574 \uc785\uc9c0\ub97c \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc874\uc2a8\uc564\ub4dc\uc874\uc2a8(Johnson &#038; Johnson)\uc758 \uce74\ube44\ud06c\ud2f0(Carvykti)\ub294 \uc5c4\uaca9\ud55c \ubbf8\uc138\uc794\uc874\uc9c8\ud658(MRD) \ub370\uc774\ud130\ub97c \ubc14\ud0d5\uc73c\ub85c \ub450 \ubc88\uc9f8\ub85c \ud070 CAR-T \ud310\ub9e4\ub7c9\uc744 \uae30\ub85d\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc911\uacac \ud601\uc2e0 \uae30\uc5c5\ub4e4\uc740 \ub3d9\uc885 \uce58\ub8cc\uc81c \ubd84\uc57c\uc5d0\uc11c \ud601\uc2e0\uc744 \uc8fc\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc54c\ub85c\uc820 \ud14c\ub77c\ud4e8\ud2f1\uc2a4(Allogene Therapeutics), CRISPR \ud14c\ub77c\ud4e8\ud2f1\uc2a4(CRISPR Therapeutics), \uc140\ub809\ud2f0\uc2a4(Cellectis)\ub294 \uc720\uc804\uc790 \ud3b8\uc9d1 \ubc0f \uba74\uc5ed \ud68c\ud53c \ubd84\uc57c\uc5d0\uc11c \uc9c0\uc801 \uc7ac\uc0b0\uc744 \ucd95\uc801\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub300\ud615 \uc81c\uc57d\uc0ac\ub4e4\uc740 \ubc14\uc774\uc624\uc5d4\ud14d(BioNTech)\uc758 \uc624\ud1a0\ub8e8\uc2a4(Autolus)\uc5d0 \ub300\ud55c 2\uc5b5 \ub2ec\ub7ec \uc18c\uc218 \uc9c0\ubd84 \ud22c\uc790\uc640 \uc560\ube0c\ube44(AbbVie)\uc758 \uc6b0\ubaa8\uc790(Umoja)\uc640\uc758 14\uc5b5 4\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\uc758 \ub9c8\uc77c\uc2a4\ud1a4 \uae30\ubc18 \uacc4\uc57d\uc5d0\uc11c \ubcfc \uc218 \uc788\ub4ef\uc774 \uc9c0\ubd84 \ud22c\uc790 \ubc0f \uc218\uc2ed\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc758 \uc635\uc158 \uacc4\uc57d\uc744 \ud1b5\ud574 \uc704\ud5d8\uc744 \ubd84\uc0b0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc81c\uc870\ub294 \uc8fc\uc694 \uaca9\uc804\uc9c0\ub85c, \uc790\ub3d9\ud654\ub41c \uc154\ud2c0\uacfc \ud3d0\uc1c4\ud615 \uc2dc\uc2a4\ud15c \uc0dd\ubb3c\ubc18\uc751\uae30\ub294 \ub9ac\ub4dc \ud0c0\uc784\uc744 \ub2e8\ucd95\ud558\uace0 \ubc30\uce58 \uc131\uacf5\ub960\uc744 \ub192\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubcd1\uc6d0 \uba74\uc81c \uc870\ud56d\uc744 \uac00\uc9c4 \ud559\uc220 \uae30\uad00\ub4e4\uc740 \ube44\uc6a9 \uae30\ubc18 \uc81c\ud488\uc744 \uc81c\uacf5\ud558\uc5ec \uc0c1\uc5c5\uc801 \uac00\uaca9 \uc0c1\ud55c\uc120\uc5d0 \uc555\ub825\uc744 \uac00\ud568\uc73c\ub85c\uc368 \uc811\uadfc\uc131\uc744 \ub354\uc6b1 \ubbfc\uc8fc\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>T\uc138\ud3ec \uba74\uc5ed\uce58\ub8cc\uc81c \uc0b0\uc5c5 \uc120\ub450 \uae30\uc5c5:<\/p>\n<p>*   \ub178\ubc14\ud2f0\uc2a4 AG (Novartis AG)<br \/>\n*   \uae38\ub9ac\uc5b4\ub4dc \uc0ac\uc774\uc5b8\uc2a4 (Gilead Sciences)<br \/>\n*   \ube0c\ub9ac\uc2a4\ud1a8 \ub9c8\uc774\uc5b4\uc2a4 \uc2a4\ud045 (Bristol Myers Squibb)<br \/>\n*   \uc874\uc2a8\uc564\ub4dc\uc874\uc2a8 (Johnson &#038; Johnson)<br \/>\n*   \uc544\uc774\uc624\ubc18\uc2a4 \ubc14\uc774\uc624\ud14c\ub77c\ud4e8\ud2f1\uc2a4 (Iovance Biotherapeutics)<\/p>\n<p>8. \ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5<\/p>\n<p>*   2025\ub144 3\uc6d4: FDA\ub294 \uc7ac\ubc1c\uc131\/\ubd88\uc751\uc131 B\uc138\ud3ec \uae09\uc131 \ub9bc\ud504\ubaa8\uad6c \ubc31\ud608\ubcd1 \uc131\uc778 \ud658\uc790\ub97c \uc704\ud55c \uc624\ubca0\uce74\ube0c\ud0c0\uc9c4 \uc624\ud1a0\ub958\uc140(Aucatzyl)\uc744 \uc2b9\uc778\ud588\uc73c\uba70, 63%\uc758 \uc644\uc804 \uad00\ud574\uc728\uc744 \ub2ec\uc131\ud588\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 2\uc6d4: \uc140\ub809\ud2f0\uc2a4(Cellectis)\ub294 UCART22 \ubc0f UCART20x22\uc5d0 \ub300\ud55c \uae0d\uc815\uc801\uc778 1\uc0c1 \ub370\uc774\ud130\ub97c \ubcf4\uace0\ud588\uc73c\uba70, \ub450 \uc81c\ud488 \ubaa8\ub450 \uc774\uc911 \ud76c\uadc0\uc758\uc57d\ud488 \uc9c0\uc815\uc744 \ubc1b\uc558\uc2b5\ub2c8\ub2e4.<br \/>\n*   2024\ub144 2\uc6d4: \ubc14\uc774\uc624\uc5d4\ud14d(BioNTech)\uacfc \uc624\ud1a0\ub8e8\uc2a4(Autolus)\ub294 2\uc5b5 \ub2ec\ub7ec\uc758 \uc9c0\ubd84 \ud22c\uc790\ub97c \ud3ec\ud568\ud558\ub294 2\uc5b5 5\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\uc758 CAR-T \ud611\ub825\uc744 \ubc1c\ud45c\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 T\uc138\ud3ec \uba74\uc5ed\uce58\ub8cc \uc2dc\uc7a5\uc758 \uc804\ubc18\uc801\uc778 \ud604\ud669, \uc131\uc7a5 \ub3d9\ub825, \uc81c\uc57d \uc694\uc778, \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21, \uacbd\uc7c1 \ud658\uacbd, \uadf8\ub9ac\uace0 \ubbf8\ub798 \uc804\ub9dd\uc744 \uc2ec\uce35\uc801\uc73c\ub85c \ubd84\uc11d\ud569\ub2c8\ub2e4.<\/p>\n<p>1. \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc131\uc7a5 \uc608\uce21<br \/>\nT\uc138\ud3ec \uba74\uc5ed\uce58\ub8cc \uc2dc\uc7a5\uc740 2030\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 35.33%\uc758 \ub192\uc740 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud558\uba70 327\uc5b5 5\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub294 \ud601\uc2e0\uc801\uc778 \uce58\ub8cc\ubc95\uc5d0 \ub300\ud55c \uc218\uc694 \uc99d\uac00\uc640 \uae30\uc220 \ubc1c\uc804\uc5d0 \ud798\uc785\uc740 \uacb0\uacfc\uc785\ub2c8\ub2e4.<\/p>\n<p>2. \uc2dc\uc7a5 \uc131\uc7a5 \ub3d9\ub825<br \/>\n\uc8fc\uc694 \uc131\uc7a5 \ub3d9\ub825\uc73c\ub85c\ub294 \ub2e4\uc74c\uacfc \uac19\uc740 \uc694\uc778\ub4e4\uc774 \uc788\uc2b5\ub2c8\ub2e4:<br \/>\n*   \uc804 \uc138\uacc4\uc801\uc73c\ub85c \uc99d\uac00\ud558\ub294 \uc554 \ubd80\ub2f4 \ubc0f \uace0\ub839\ud654 \uc778\uad6c: \uc554 \ud658\uc790 \uc218 \uc99d\uac00\uc640 \uace0\ub839\ud654\ub294 T\uc138\ud3ec \uce58\ub8cc\uc81c\uc758 \ud544\uc694\uc131\uc744 \uc99d\ub300\uc2dc\ud0b5\ub2c8\ub2e4.<br \/>\n*   T\uc138\ud3ec \uce58\ub8cc\uc81c\uc758 \uc801\uc751\uc99d \ud655\ub300 \ubc0f \ub77c\ubca8 \ud655\uc7a5: \ub2e4\uc591\ud55c \uc9c8\ubcd1\uc73c\ub85c \uce58\ub8cc \ubc94\uc704\uac00 \ub113\uc5b4\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc6b0\ud638\uc801\uc778 \uaddc\uc81c \uacbd\ub85c \ubc0f \uc2e0\uc18d \uc2b9\uc778 \ud504\ub85c\uadf8\ub7a8: \uac01\uad6d \uc815\ubd80 \ubc0f \uaddc\uc81c \uae30\uad00\uc758 \uc9c0\uc6d0\uc774 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud569\ub2c8\ub2e4.<br \/>\n*   \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc \uc778\ud504\ub77c\uc5d0 \ub300\ud55c \ud22c\uc790 \uc99d\uac00: \uc5f0\uad6c \uac1c\ubc1c \ubc0f \uc0dd\uc0b0 \uc5ed\ub7c9 \uac15\ud654\uac00 \uc774\ub8e8\uc5b4\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc138\ud3ec \uacf5\ud559 \ubc0f \uc81c\uc870 \uc790\ub3d9\ud654 \uae30\uc220 \ubc1c\uc804: \uc0dd\uc0b0 \ud6a8\uc728\uc131 \ubc0f \uc811\uadfc\uc131\uc774 \ud5a5\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc81c\uc57d, \ubc14\uc774\uc624\ud14d, \ud559\uacc4 \uac04\uc758 \uc804\ub7b5\uc801 \ud611\ub825 \ubc0f \uc81c\ud734: \uc2dc\ub108\uc9c0 \ud6a8\uacfc\ub97c \ud1b5\ud55c \ud601\uc2e0 \uac00\uc18d\ud654\uac00 \uae30\ub300\ub429\ub2c8\ub2e4.<\/p>\n<p>3. \uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778<br \/>\n\uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc8fc\uc694 \uc694\uc778\ub4e4\uc740 \ub2e4\uc74c\uacfc \uac19\uc2b5\ub2c8\ub2e4:<br \/>\n*   \ub192\uc740 \uce58\ub8cc \ube44\uc6a9 \ubc0f \ubd88\ud655\uc2e4\ud55c \ubcf4\ud5d8 \uc0c1\ud658 \ud658\uacbd: 30\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 425\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub974\ub294 \ub192\uc740 \uce58\ub8cc \ube44\uc6a9\uc740 \ud658\uc790 \uc811\uadfc\uc131\uc744 \uc81c\ud55c\ud558\uba70, \ud2b9\ud788 \uc2e0\ud765 \uc2dc\uc7a5\uc5d0\uc11c\ub294 \ubcf4\ud5d8 \uc0c1\ud658 \uccb4\uacc4\uac00 \ubbf8\ud761\ud569\ub2c8\ub2e4.<br \/>\n*   \ubcf5\uc7a1\ud55c \uc81c\uc870 \uacf5\uae09\ub9dd \ubc0f \uc0dd\uc0b0 \ub2a5\ub825 \uc81c\uc57d: \ub9de\ucda4\ud615 \uce58\ub8cc\uc81c\uc758 \ud2b9\uc131\uc0c1 \uc81c\uc870 \uacfc\uc815\uc774 \ubcf5\uc7a1\ud558\uace0 \ub300\ub7c9 \uc0dd\uc0b0\uc5d0 \uc5b4\ub824\uc6c0\uc774 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc0ac\uc774\ud1a0\uce74\uc778 \ubc29\ucd9c \uc99d\ud6c4\uad70(CRS) \ubc0f \uc2e0\uacbd\ub3c5\uc131 \ub4f1 \uc548\uc804\uc131 \ubb38\uc81c: \uc2ec\uac01\ud55c \ubd80\uc791\uc6a9 \ubc1c\uc0dd \uac00\ub2a5\uc131\uc73c\ub85c \uc778\ud574 \uc5c4\uaca9\ud55c \uc0ac\ud6c4 \uad00\ub9ac \ubc0f \uaddc\uc81c \uac10\ub3c5\uc774 \ud544\uc694\ud569\ub2c8\ub2e4.<br \/>\n*   \ub300\uccb4 \uba74\uc5ed\uce58\ub8cc \ubc29\uc2dd\uacfc\uc758 \uacbd\uc7c1 \uc555\ub825: \ub2e4\ub978 \ud601\uc2e0\uc801\uc778 \uce58\ub8cc\ubc95\ub4e4\uacfc\uc758 \uacbd\uc7c1\uc774 \uc2ec\ud654\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>4. \uc2dc\uc7a5 \uc138\ubd84\ud654 \ubc0f \uc8fc\uc694 \ud2b8\ub80c\ub4dc<br \/>\n*   \uce58\ub8cc \uc720\ud615\ubcc4: \ud604\uc7ac \uc0c1\uc5c5\uc801 \ub9e4\ucd9c\uc740 \uc790\uac00(Autologous) CAR-T \uc81c\ud488\uc774 95.7%\ub97c \ucc28\uc9c0\ud558\uba70 \uc9c0\ubc30\uc801\uc774\uc9c0\ub9cc, \ub3d9\uc885(Allogeneic) T\uc138\ud3ec \uce58\ub8cc\uc81c\ub294 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \ud558\uc704 \ubd80\ubb38\uc73c\ub85c \uc8fc\ubaa9\ubc1b\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc801\uc751\uc99d\ubcc4: \ud608\uc561\uc554(Hematologic Malignancies)\uc774 \uc8fc\uc694 \uc801\uc751\uc99d\uc774\uba70, \uace0\ud615\uc554(Solid Tumors), \uc790\uac00\uba74\uc5ed\uc9c8\ud658(Autoimmune Diseases), \ubc14\uc774\ub7ec\uc2a4 \uac10\uc5fc \ub4f1\uc73c\ub85c \uc801\uc6a9 \ubc94\uc704\uac00 \ud655\ub300\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uc911\uad6d, \uc77c\ubcf8, \ud55c\uad6d\uc758 \uc2b9\uc778 \uac00\uc18d\ud654 \ubc0f \uc0dd\uc0b0 \ub2a5\ub825 \ud655\ucda9\uc5d0 \ud798\uc785\uc5b4 \uc5f0\ud3c9\uade0 25.2%\ub85c \uac00\uc7a5 \ub192\uc740 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ubd81\ubbf8\uc640 \uc720\ub7fd \ub610\ud55c \uc911\uc694\ud55c \uc2dc\uc7a5\uc785\ub2c8\ub2e4.<\/p>\n<p>5. \uae30\uc220 \ubc0f \uaddc\uc81c \ub3d9\ud5a5<br \/>\n\uc790\ub3d9\ud654\ub41c \ud3d0\uc1c4\ud615 \ubc14\uc774\uc624\ub9ac\uc561\ud130 \uc2dc\uc2a4\ud15c\uacfc \uc720\uc804\uc790 \ud3b8\uc9d1 \uae30\ubc18\uc758 \ub3d9\uc885 \ud50c\ub7ab\ud3fc\uc740 \uc0dd\uc0b0 \ube44\uc6a9\uc744 \uc808\uac10\ud558\uace0 &#8216;\uae30\uc131\ud488(off-the-shelf)&#8217; \ud615\ud0dc\uc758 \uce58\ub8cc\uc81c \uc81c\uacf5\uc744 \uac00\ub2a5\ud558\uac8c \ud558\uc5ec \uc81c\uc870 \uacbd\uc81c\uc131\uc744 \uc7ac\uc815\uc758\ud560 \uc7a0\uc7ac\ub825\uc744 \uac00\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uaddc\uc81c \uce21\uba74\uc5d0\uc11c\ub294 \uc0ac\uc774\ud1a0\uce74\uc778 \ubc29\ucd9c \uc99d\ud6c4\uad70 \ubc0f \uc2e0\uacbd\ub3c5\uc131 \ub4f1 \uc548\uc804\uc131 \ubb38\uc81c\uc5d0 \ub300\ud55c \uc9c0\uc18d\uc801\uc778 \ubaa8\ub2c8\ud130\ub9c1\uacfc \ud2b9\uc218 \uc911\ud658\uc790\uc2e4(ICU) \uc900\ube44\uac00 \uac15\uc870\ub429\ub2c8\ub2e4.<\/p>\n<p>6. \uacbd\uc7c1 \ud658\uacbd<br \/>\nNovartis AG, Gilead Sciences (Kite Pharma), Bristol Myers Squibb, Johnson &#038; Johnson \/ Legend Biotech \ub4f1 \ub2e4\uc218\uc758 \uae00\ub85c\ubc8c \uc81c\uc57d \ubc0f \ubc14\uc774\uc624 \uae30\uc5c5\ub4e4\uc774 \uc2dc\uc7a5\uc5d0 \ucc38\uc5ec\ud558\uc5ec \uacbd\uc7c1\ud558\uace0 \uc788\uc73c\uba70, \uc774\ub4e4 \uae30\uc5c5\uc758 \uc804\ub7b5\uc801 \uc815\ubcf4, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ub3d9\ud5a5 \ub4f1\uc774 \ubcf4\uace0\uc11c\uc5d0 \uc0c1\uc138\ud788 \ud3ec\ud568\ub418\uc5b4 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<br \/>\n\ubcf4\uace0\uc11c\ub294 \ubbf8\uac1c\ucc99 \uc601\uc5ed(White-space) \ubc0f \ubbf8\ucda9\uc871 \uc218\uc694(Unmet-Need)\uc5d0 \ub300\ud55c \ud3c9\uac00\ub97c \ud1b5\ud574 \uc2dc\uc7a5\uc758 \uc0c8\ub85c\uc6b4 \uae30\ud68c\ub97c \uc81c\uc2dc\ud558\uba70, \uc9c0\uc18d\uc801\uc778 \uc5f0\uad6c \uac1c\ubc1c\uacfc \uae30\uc220 \ud601\uc2e0\uc744 \ud1b5\ud574 T\uc138\ud3ec \uba74\uc5ed\uce58\ub8cc \uc2dc\uc7a5\uc774 \ub354\uc6b1 \ud655\uc7a5\ub420 \uac83\uc73c\ub85c \uc804\ub9dd\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-48889","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/48889"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=48889"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/48889\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=48889"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=48889"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=48889"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}